Bausch Health’s Liver Drug Fails in Late-Stage Trials
Bausch Health said its experimental liver treatment did not meet goals in Phase 3 trials, sending shares lower in early trading.
Feed↓
/ What's going on?
Filter:
Enphase Energy Jumps as Investors Return to Clean Energy Stocks
Enphase Energy shares surged as investors moved back into clean energy stocks after tariff fears eased. Analyst upgrades and improving fundamentals supported the rally.
Erayak Sees Surge in U.S. Demand for Portable Generators During Winter Storms
Erayak Power Solution Group reports a sharp rise in U.S. generator sales due to winter storms, tight inventory, and plans to expand its emergency power product lineup in 2026.
China Greenlights Nvidia H200 AI Chip Orders as Tech Giants Prepare Major Purchases
Chinese regulators grant approval for Alibaba, Tencent, and ByteDance to order Nvidia H200 AI chips, potentially unlocking $30 billion in revenue amid US-China trade tensions.
Fortinet Stock Upgraded to Buy as Analysts See Stable Growth Ahead
TD Cowen upgrades Fortinet to Buy, citing stable performance, upside to revenue, and AI boosting—not replacing—security software.
Ericsson Beats Forecasts, Announces Historic Share Buyback Program
Ericsson (ERIC) reports strong Q4 2025 earnings and launches first-ever share buyback worth $1.7B. Swedish telecom giant beats estimates despite flat market conditions.